Drugstore chain CVS disclosed Thursday that it will sell a rival, generic version of Mylan's EpiPen for about one-sixth of the price, according to CNN Money.
CVS will sell a generic version of Impax Laboratories' Adrenaclick treatment for $109.99 per two-pack, down from $200. In comparison, Mylan's generic epinephrine auto-injector cost $300 for a two-pack, about 50 percent less than EpiPen's $608 list price. Mylan announced it would be releasing the generic device in December after taking widespread criticism for raising its price for EpiPen by more than 400 percent since 2009.
In other Mylan news, Bloomfield, Conn.-based health insurer Cigna announced it is dropping coverage for Mylan's EpiPen and EpiPen Jr. auto-injectors in favor of its generic alternative, according to the payer's prescription drug list changes.